Malgorzata Monika Trawinska Selected Research

Malgorzata Monika Trawinska Research Topics

Disease

19	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 06/2007
4	Neoplasms (Cancer) 01/2022 - 01/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2017
2	Disease Progression 02/2024 - 02/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2020
2	Iron Overload 01/2022 - 01/2019
2	Blast Crisis (Blast Phase) 11/2021 - 01/2020
2	Leukemia 04/2010 - 02/2010
1	Residual Neoplasm 08/2023
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Pleural Effusion (Pleural Effusions) 11/2021
1	Dyslipidemias (Dyslipidemia) 08/2021
1	COVID-19 01/2021
1	Hypertension (High Blood Pressure) 07/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2013
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Hemorrhage 01/2011
1	Hematologic Neoplasms (Hematological Malignancy) 01/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2009
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2009
1	Neoplasm Metastasis (Metastasis) 09/2008
1	Chromosome Aberrations (Chromosome Abnormalities) 06/2007
1	Philadelphia Chromosome 06/2007

Drug/Important Bio-Agent (IBA)

11	Tyrosine Kinase InhibitorsIBA 03/2022 - 08/2016
4	ponatinibIBA 11/2023 - 01/2019
3	nilotinib FDA Link 11/2023 - 01/2019
3	bosutinibIBA 08/2021 - 01/2019
3	Rituximab (Mabthera)FDA Link 03/2016 - 07/2009
2	Deferasirox FDA Link 01/2022 - 01/2019
2	Dasatinib (BMS 354825)FDA Link 11/2021 - 01/2019
2	LDL Lipoproteins (beta Lipoproteins)IBA 08/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 02/2010
2	Decitabine FDA Link 01/2018 - 10/2017
1	RNA (Ribonucleic Acid)IBA 08/2023
1	Anaplastic Lymphoma KinaseIBA 12/2022
1	ruxolitinibIBA 01/2022
1	amsonic acid (DAS)IBA 11/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021
1	oxidized low density lipoproteinIBA 08/2021
1	Angiotensin Receptor AntagonistsIBA 07/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	LDL CholesterolIBA 01/2020
1	NucleophosminIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2019
1	SteroidsIBA 03/2016
1	Immunoglobulins (Immunoglobulin)IBA 12/2015
1	KIR ReceptorsIBA 12/2015
1	Bendamustine Hydrochloride FDA Link 08/2013
1	SuspensionsIBA 01/2011
1	Warfarin (Coumadin)FDA LinkGeneric 01/2011
1	AnticoagulantsIBA 01/2011
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2011
1	Caspase 9IBA 04/2010
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2010
1	cold agglutininsIBA 07/2009
1	Diphosphonates (Bisphosphonates)IBA 09/2008
1	RadiopharmaceuticalsIBA 09/2008
1	SamariumIBA 09/2008
1	Imatinib Mesylate (Gleevec)FDA Link 06/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2007

Therapy/Procedure

6	Therapeutics 02/2024 - 04/2010
1	Secondary Prevention 01/2019
1	Radiotherapy 09/2009
1	VAP-cyclo protocol 09/2009
1	Drug Therapy (Chemotherapy) 09/2008
1	Aftercare (After-Treatment) 06/2007